You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Scopolamine

Showing 1 - 25 of 160
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))

Not yet recruiting
  • Muscarinic Receptor Occupancy
  • Scopolamine
  • [11C]EMO ([11C]LSN3172176)
  • New Haven, Connecticut
    Yale University
Aug 31, 2023

Motion Sickness, Space, Motion Sickness, Sea Sickness Trial in Houston (DPI-386 Nasal Gel, Placebo Nasal Gel)

Recruiting
  • Motion Sickness, Space
  • +2 more
  • DPI-386 Nasal Gel
  • Placebo Nasal Gel
  • Houston, Texas
    NASA Johnson Space Center Neuroscience Laboratory
May 23, 2023

Scopolamine, Motion Sickness Trial in Lebanon (Scopolamine, Placebo)

Active, not recruiting
  • Scopolamine
  • Motion Sickness
  • Scopolamine
  • Placebo
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Oct 22, 2022

Motion Sickness, Space, Motion Simulation, Parabolic Flight Trial in Houston (DPI-386 Nasal Gel, Other (e.g., promethazine,

Recruiting
  • Motion Sickness, Space
  • +2 more
  • DPI-386 Nasal Gel
  • Other (e.g., promethazine, meclizine)
  • Houston, Texas
    NASA Johnson Space Center Neuroscience Laboratory
May 9, 2023

Scopolamine Causing Adverse Effects in Therapeutic Use Trial in Baltimore (Scopolamine Hydrobromide Trihydrate)

Terminated
  • Scopolamine Causing Adverse Effects in Therapeutic Use
  • Scopolamine Hydrobromide Trihydrate
  • Baltimore, Maryland
    Pharmaron
May 31, 2022

Epilepsy, Seizures, Cognitive Impairment, Mild Trial in Dallas (Scopolamine (5ug/kg), Placebo)

Recruiting
  • Epilepsy
  • +4 more
  • Scopolamine (5ug/kg)
  • Placebo
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Oct 20, 2022

Obesity, Morbid, Surgery, Bariatric Surgery Candidate Trial in Sacramento (Neurontin, Dilaudid Injectable Product, Marcaine

Recruiting
  • Obesity, Morbid
  • +2 more
  • Sacramento, California
    UC Davis Health
Mar 11, 2022

Depressive Disorder, Treatment-Resistant Trial in Saint Louis (Ketamine, Clonidine, )

Completed
  • Depressive Disorder, Treatment-Resistant
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 22, 2022

A Novel Usage of Transdermal Scopolamine in Reducing Narcotic

Recruiting
  • Post Operative Pain Management
  • Scopolamine Patch (Transderm V)
  • Pittsburgh, Pennsylvania
    Falk Clinic, 3601 Fifth Ave., Suite 6B
Jun 7, 2021

Alzheimer's Disease, Dementia Trial in Lexington (Placebo, Medication Therapy Management (MTM), Scopolamine patch)

Completed
  • Alzheimer's Disease
  • Dementia
  • Placebo
  • +2 more
  • Lexington, Kentucky
    University of Kentucky
Nov 8, 2021

Motion Sickness Trial in Santa Monica (DPI-386 Nasal Gel, Placebo)

Recruiting
  • Motion Sickness
  • DPI-386 Nasal Gel
  • Placebo
  • Santa Monica, California
    Santa Monica Clinical Trials
Sep 16, 2022

Hallucinations, Auditory, Psychosis Trial in New Haven (Rivastigmine Transdermal Product, Scopolamine, Placebo)

Recruiting
  • Hallucinations, Auditory
  • Psychosis
  • Rivastigmine Transdermal Product
  • +2 more
  • New Haven, Connecticut
    Connecticut Mental Health Center
Mar 2, 2022

Bipolar Disorder Depression Trial in Galway (Scopolamine, Placebo)

Recruiting
  • Bipolar Disorder Depression
  • Scopolamine
  • Placebo
  • Galway, County Galway, Ireland
    University Hospital Galway
May 6, 2021

Post-operative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy Trial in Stony Brook (Aprepitant 80Mg Oral Capsule,

Completed
  • Post-operative Nausea and Vomiting
  • Laparoscopic Sleeve Gastrectomy
  • Aprepitant 80Mg Oral Capsule
  • +12 more
  • Stony Brook, New York
    Stony Brook University Hospital
Mar 11, 2022

Motion Sickness Trial in Santa Monica (DPI-386 Nasal Gel, Placebo)

Completed
  • Motion Sickness
  • DPI-386 Nasal Gel
  • Placebo
  • Santa Monica, California
    Santa Monica Clinical Trials
Sep 16, 2021

Sedation, Bronchoscopy Trial (Midazolam, Propofol-Lipuro, morphine-scopolamine)

Completed
Has Results
  • Sedation, Bronchoscopy
  • (no location specified)
Dec 31, 2020

Amyotrophic Lateral Sclerosis, Respiratory Function, Scopolamine Trial in Shanghai (Scopolamine, atropine, edaravone and

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • +2 more
  • Scopolamine, atropine, edaravone and dexmedetomidine
  • Edaravone
  • Shanghai, Shanghai, China
    Department of neurology, Ruijin Hospital, Shanghai Jiao Tong Uni
Oct 9, 2020

Mood Disorders, Healthy, Unipolar Depression Trial run by the NIMH (Scopolamine Nasal Spray)

Terminated
  • Mood Disorders
  • +3 more
  • Scopolamine Nasal Spray
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 17, 2021

MDD (MDD) Trial in Long Beach (Scopolamine)

Unknown status
  • Major Depressive Disorder (MDD)
  • Scopolamine
  • Long Beach, California
    Collaborative Neuroscience Network, LLC
Feb 13, 2020

Motion Sickness Trial in Dayton (scopolamine HBr, Transdermal Scopolamine)

Unknown status
  • Motion Sickness
  • scopolamine HBr
  • Transdermal Scopolamine
  • Dayton, Ohio
    NAMRU-D
Feb 13, 2020

Motion Sickness Trial in Long Beach (Scopolamine Nasal Gel, Placebo)

Completed
  • Motion Sickness
  • Scopolamine Nasal Gel
  • Placebo
  • Long Beach, California
    Collaborative Neuroscience Network, LLC
Dec 2, 2019

Healthy Volunteers Trial in Glendale (Scopolamine, TAK-071, Donepezil)

Terminated
Has Results
  • Healthy Volunteers
  • Scopolamine
  • +5 more
  • Glendale, California
    (unnamed)
Mar 15, 2019

Social Anxiety Disorder Trial in Los Angeles (Scopolamine, intranasal )

Completed
  • Social Anxiety Disorder
  • Scopolamine
  • intranasal placebo
  • Los Angeles, California
    University of California, Los Angeles
Oct 3, 2019

Cognitive Impairment, Alzheimer Trial in France (THN 201, Donepezil, Placebo)

Completed
  • Cognitive Impairment
  • Alzheimer Disease
  • THN 201
  • +2 more
  • Bordeaux, France
  • +6 more
Jan 21, 2020

Subjective Cognitive Decline Trial in Nashville (Mecamylamine Challenge, Placebo Comparator Challenge)

Recruiting
  • Subjective Cognitive Decline
  • Mecamylamine Challenge
  • Placebo Comparator Challenge
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Dec 19, 2022